Dr. Halmai's research goals are to investigate the role of modulating epigenetic signatures in neurodevelopmental disease; build foundational ‘omics’ datasets and develop novel tools to advance clinical therapies for those currently suffering from untreatable childhood neurological disorders. Technological advancements in epigenome editing has vastly increased our ability to make the undruggable genome druggable. Dr. Halmai's lab focuses on a basic science approach to big data driven design of novel tools for epigenome editors to elucidate the role of chromatin biology in neurodevelopmental disorders. 

Accepting students per funding availability.